FTCM
ITCI

First Trust Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

First Trust Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-719,552
Closed -$94.9M – 145
2025
Q1 		$94.9M Buy
+719,552
New +$89.7M 6.86% 1

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Capital Management's ITCI Position: Q2 2025 in Review

First Trust Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 719,552 shares — an estimated $94.9M sold.

First Trust Capital Management first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $94.9M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • First Trust Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • First Trust Capital Management sold 719,552 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $94.9M.
  • First Trust Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • First Trust Capital Management's Intra-Cellular Therapies Inc. position peaked at $94.9M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on First Trust Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.